Literature DB >> 25899551

Cochlear Implantation in Children With Autism Spectrum Disorder.

Adrien A Eshraghi1, Ronen Nazarian, Fred F Telischi, Diane Martinez, Annelle Hodges, Sandra Velandia, Ivette Cejas-Cruz, Thomas J Balkany, Kaming Lo, Dustin Lang.   

Abstract

OBJECTIVE: To assess the outcome of cochlear implantation in children with autism spectrum disorder (ASD). STUDY
DESIGN: Retrospective case review and survey.
SETTING: Tertiary referral center. PATIENTS: Children who meet criteria for cochlear implantation and diagnosis of ASD. MAIN OUTCOME MEASURES: Receptive and expressive language scores and parental survey data.
RESULTS: Fifteen patients with history of ASD and cochlear implantation were analyzed and compared with 15 patients who received cochlear implant and have no other disability. Postoperatively, more than 67% of children with ASD significantly improved their speech perception skills, and 60% significantly improved their speech expression skills, whereas all patients in the control group showed significant improvement in both aspects. The top 3 reported improvements after cochlear implantation were name recognition, response to verbal requests, and enjoyment of music. Of all behavioral aspects, the use of eye contact was the least improved. Survey results in regard to improvements in patient interaction were more subtle when compared with those related to sound and speech perception. The most improved aspects in the ASD patients' lives after cochlear implantation seemed to be attending to other people's requests and conforming to family routines. Of note, awareness of the child's environment is the most highly ranked improvement attributed to the cochlear implant.
CONCLUSION: Cochlear implants are effective and beneficial for hearing impaired members of the ASD population, although development of language may lag behind that of implanted children with no additional disabilities. Significant speech perception and overall behavior improvement are noted.

Entities:  

Mesh:

Year:  2015        PMID: 25899551      PMCID: PMC4537326          DOI: 10.1097/MAO.0000000000000757

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  37 in total

1.  Does meningitis after cochlear implantation remain a concern in 2011?

Authors:  Anil K Lalwani; Noel L Cohen
Journal:  Otol Neurotol       Date:  2012-01       Impact factor: 2.311

2.  Cochlear implants in special cases: deafness in the presence of disabilities and/or associated problems.

Authors:  R Filipo; E Bosco; P Mancini; D Ballantyne
Journal:  Acta Otolaryngol Suppl       Date:  2004-05

3.  Cochlear implantation in prelingually deaf persons with additional disability.

Authors:  A Daneshi; S Hassanzadeh
Journal:  J Laryngol Otol       Date:  2006-12-06       Impact factor: 1.469

4.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression.

Authors:  H Jyonouchi; S Sun; H Le
Journal:  J Neuroimmunol       Date:  2001-11-01       Impact factor: 3.478

5.  Pervasive developmental disorders in preschool children: confirmation of high prevalence.

Authors:  Suniti Chakrabarti; Eric Fombonne
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

Review 6.  Immunizations, immunology, and autism.

Authors:  Michael G Chez; Kathleen Chin; Paul C Hung
Journal:  Semin Pediatr Neurol       Date:  2004-09       Impact factor: 1.636

7.  Auditory skills development among children with developmental delays and cochlear implants.

Authors:  Susan Wiley; Jareen Meinzen-Derr; Daniel Choo
Journal:  Ann Otol Rhinol Laryngol       Date:  2008-10       Impact factor: 1.547

Review 8.  Identification and evaluation of children with autism spectrum disorders.

Authors:  Chris Plauché Johnson; Scott M Myers
Journal:  Pediatrics       Date:  2007-10-29       Impact factor: 7.124

9.  Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain.

Authors:  S Rose; S Melnyk; O Pavliv; S Bai; T G Nick; R E Frye; S J James
Journal:  Transl Psychiatry       Date:  2012-07-10       Impact factor: 6.222

10.  Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA.

Authors:  Martyn A Sharpe; Andrew D Livingston; David S Baskin
Journal:  J Toxicol       Date:  2012-06-28
View more
  6 in total

Review 1.  Central Auditory Processing Disorders in Individuals with Autism Spectrum Disorders

Authors:  Emre Ocak; Rebecca S. Eshraghi; Ali Danesh; Rahul Mittal; Adrien A. Eshraghi
Journal:  Balkan Med J       Date:  2018-06-28       Impact factor: 2.021

2.  Cochlear Implantation Can Improve Auditory Skills, Language and Social Engagement of Children With Autism Spectrum Disorder.

Authors:  Carolyn M Jenks; Stephen R Hoff; Jennifer Haney; Elizabeth Tournis; Denise Thomas; Nancy M Young
Journal:  Otol Neurotol       Date:  2022-03-01       Impact factor: 2.311

Review 3.  Guidelines for cochlear implantation in Saudi Arabia.

Authors:  Musaed A Alzahrani; Nader F Aldajani; Saeed A Alghamdi
Journal:  Saudi Med J       Date:  2021-12       Impact factor: 1.422

Review 4.  Current trends in outcome studies for children with hearing loss and the need to establish a comprehensive framework of measuring outcomes in children with hearing loss in China.

Authors:  Xueman Liu
Journal:  J Otol       Date:  2016-05-24

Review 5.  Cochlear implant in patients with autistic spectrum disorder-a systematic review.

Authors:  Flávia da Silva Tavares; Yaná Jinkings Azevedo; Luísa da Matta Machado Fernandes; Alice Takeuti; Larissa Vilela Pereira; Alelluia Lima Losno Ledesma; Fayez Bahmad
Journal:  Braz J Otorhinolaryngol       Date:  2021-01-02

6.  Cochlear implantation in autistic children with profound sensorineural hearing loss.

Authors:  Magdalena Lachowska; Agnieszka Pastuszka; Zuzanna Łukaszewicz-Moszyńska; Lidia Mikołajewska; Kazimierz Niemczyk
Journal:  Braz J Otorhinolaryngol       Date:  2016-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.